Neamine dimers targeting the HIV-1 TAR RNA

The natural antibiotic agent neomycin binds strongly to HIV TAR RNA through the predominant interactions of its neamine core and inhibits the TAR-Tat protein association necessary for viral RNA transactivation. In the search for new antiviral agents, neamine dimers were found to be able to inhibit t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2005-11, Vol.15 (21), p.4651-4655
Hauptverfasser: Riguet, Emmanuel, Désiré, Jérôme, Boden, Oliver, Ludwig, Verena, Göbel, Michael, Bailly, Christian, Décout, Jean-Luc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The natural antibiotic agent neomycin binds strongly to HIV TAR RNA through the predominant interactions of its neamine core and inhibits the TAR-Tat protein association necessary for viral RNA transactivation. In the search for new antiviral agents, neamine dimers were found to be able to inhibit the TAR-Tat association, with IC 50 values 17–85 times better than that obtained with neomycin. Natural aminoglycoside antibiotics, such as neomycin, target bacterial ribosomal RNA. Neomycin also binds strongly to HIV TAR and RRE RNA through the predominant interactions of its neamine core. In the search for antiviral agents targeting multiple binding sites for aminoglycosides in RNA, we report here the synthesis of new neamine dimers and a trimer in which the neamine cores are connected by different linking chains attached at the 4′- and/or 5-positions. Inhibition of TAR-Tat complexation by these oligomers was studied via fluorimetric binding assays performed under two ionic strengths. All dimers strongly inhibit TAR-Tat association, with IC 50 values 17–85 times better than the value obtained with neomycin. These results demonstrate that modifying neamine at the 4′- or the 5-position is a promising strategy in the search for antiviral agents.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2005.07.082